EP1108031A2 - 17 kda schaumprotein - Google Patents
17 kda schaumproteinInfo
- Publication number
- EP1108031A2 EP1108031A2 EP99943182A EP99943182A EP1108031A2 EP 1108031 A2 EP1108031 A2 EP 1108031A2 EP 99943182 A EP99943182 A EP 99943182A EP 99943182 A EP99943182 A EP 99943182A EP 1108031 A2 EP1108031 A2 EP 1108031A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- kda
- foam
- protein
- acid sequence
- foam protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006260 foam Substances 0.000 title claims abstract description 496
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 463
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 375
- 235000013405 beer Nutrition 0.000 claims abstract description 120
- 238000000034 method Methods 0.000 claims abstract description 66
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 55
- 230000002708 enhancing effect Effects 0.000 claims abstract description 9
- 235000018102 proteins Nutrition 0.000 claims description 365
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 98
- 241000196324 Embryophyta Species 0.000 claims description 73
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 60
- 210000004027 cell Anatomy 0.000 claims description 50
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 46
- 235000007238 Secale cereale Nutrition 0.000 claims description 46
- 235000021307 Triticum Nutrition 0.000 claims description 45
- 235000013339 cereals Nutrition 0.000 claims description 41
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 40
- 241000209056 Secale Species 0.000 claims description 35
- 108010025221 plasma protein Z Proteins 0.000 claims description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 27
- 238000005187 foaming Methods 0.000 claims description 26
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 25
- 235000001014 amino acid Nutrition 0.000 claims description 24
- 108010068370 Glutens Proteins 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 22
- 229920001184 polypeptide Polymers 0.000 claims description 20
- 150000001413 amino acids Chemical class 0.000 claims description 19
- 239000000523 sample Substances 0.000 claims description 17
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 16
- 230000009261 transgenic effect Effects 0.000 claims description 14
- 239000004464 cereal grain Substances 0.000 claims description 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 10
- 239000011593 sulfur Substances 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 230000031787 nutrient reservoir activity Effects 0.000 claims description 9
- 108060006613 prolamin Proteins 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- 238000009396 hybridization Methods 0.000 claims description 8
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 7
- 238000004890 malting Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 210000005253 yeast cell Anatomy 0.000 claims description 7
- 238000003018 immunoassay Methods 0.000 claims description 6
- 238000009825 accumulation Methods 0.000 claims description 5
- 210000004899 c-terminal region Anatomy 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 229940098396 barley grain Drugs 0.000 claims description 4
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 2
- 241000209219 Hordeum Species 0.000 claims 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 239000004382 Amylase Substances 0.000 claims 1
- 101150091027 ale1 gene Proteins 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 18
- 235000013361 beverage Nutrition 0.000 abstract description 5
- 240000005979 Hordeum vulgare Species 0.000 description 97
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 55
- 244000098338 Triticum aestivum Species 0.000 description 44
- 239000000047 product Substances 0.000 description 39
- 239000002773 nucleotide Substances 0.000 description 30
- 125000003729 nucleotide group Chemical group 0.000 description 30
- 239000002299 complementary DNA Substances 0.000 description 28
- 230000014509 gene expression Effects 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 25
- 238000002965 ELISA Methods 0.000 description 24
- 239000013615 primer Substances 0.000 description 22
- 230000009466 transformation Effects 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 108091026890 Coding region Proteins 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 18
- 239000012634 fragment Substances 0.000 description 15
- 238000007792 addition Methods 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- 230000001105 regulatory effect Effects 0.000 description 12
- 244000082988 Secale cereale Species 0.000 description 11
- 238000005188 flotation Methods 0.000 description 11
- 235000015095 lager Nutrition 0.000 description 11
- 238000012286 ELISA Assay Methods 0.000 description 10
- 230000010354 integration Effects 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 10
- 238000001262 western blot Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000011002 quantification Methods 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 8
- 101710159910 Movement protein Proteins 0.000 description 8
- 102100024147 Protein phosphatase 1 regulatory subunit 14A Human genes 0.000 description 8
- 108700019146 Transgenes Proteins 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical group BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 229920002684 Sepharose Polymers 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000005360 mashing Methods 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 5
- 241001123227 Saccharomyces pastorianus Species 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 238000013124 brewing process Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000008488 polyadenylation Effects 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101710196809 Non-specific lipid-transfer protein 1 Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000004255 ion exchange chromatography Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 108020005065 3' Flanking Region Proteins 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 238000011426 transformation method Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 101710130006 Beta-glucanase Proteins 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 2
- 229910001863 barium hydroxide Inorganic materials 0.000 description 2
- 229940069780 barley extract Drugs 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- WOAFDHWYKSOANX-UHFFFAOYSA-N diisopropyl methylphosphonate Chemical compound CC(C)OP(C)(=O)OC(C)C WOAFDHWYKSOANX-UHFFFAOYSA-N 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108010053156 lipid transfer protein Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 230000036963 noncompetitive effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000007030 peptide scission Effects 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
- PQMRRAQXKWFYQN-UHFFFAOYSA-N 1-phenyl-2-sulfanylideneimidazolidin-4-one Chemical compound S=C1NC(=O)CN1C1=CC=CC=C1 PQMRRAQXKWFYQN-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 101100107610 Arabidopsis thaliana ABCF4 gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 101710112164 Cytochrome b6-f complex subunit 4 Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101710087459 Gamma-gliadin Proteins 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 101000892448 Neisseria gonorrhoeae Type II restriction enzyme NgoMIV Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000178960 Paenibacillus macerans Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 239000011542 SDS running buffer Substances 0.000 description 1
- 101100068078 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCN4 gene Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000003370 dye binding method Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000014726 immortalization of host cell Effects 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 101150047627 pgk gene Proteins 0.000 description 1
- 238000000819 phase cycle Methods 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 239000007981 phosphate-citrate buffer Substances 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000001273 protein sequence alignment Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007261 sc medium Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- AIDBEARHLBRLMO-UHFFFAOYSA-M sodium;dodecyl sulfate;2-morpholin-4-ylethanesulfonic acid Chemical compound [Na+].OS(=O)(=O)CCN1CCOCC1.CCCCCCCCCCCCOS([O-])(=O)=O AIDBEARHLBRLMO-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000006032 tissue transformation Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C5/00—Other raw materials for the preparation of beer
- C12C5/02—Additives for beer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Definitions
- This invention relates to a novel gene sequence encoding a foam- related protein. More specifically, the invention relates to a nucleic acid sequence and the 17 kDa Foam Protein it encodes, which protein is useful to enhance the production of foaming beverages, including beer.
- foam properties are an important parameter in high quality beverages.
- Formation of a stable head of foam on pouring a beverage such as beer is an important quality parameter considered by consumers as a vital characteristic.
- Beer proteins range in molecular weight from small polypeptides to more than 150 kDa.
- the present invention describes the purification of a 17 kDa Foam Protein from beer, from barley, from first wort and from rye; the characterization of the 17 kDa Foam Protein with respect to sequence and structure; the establishment of ELISA assays for quantification of the 17 kDa Foam Protein; and the use of the 17 kDa Foam Protein to enhance foam production.
- the 17 kDa Foam Protein has been demonstrated herein to have a positive effect on foam potential and on foam stability.
- the instant invention includes a novel 17 kDa Foam Protein, nucleic acid sequences encoding the protein, methods for enhancing foam quality, and methods for producing enhanced amounts of the protein in host cells, including yeast, plant cells and plants.
- the invention further includes anti-17 kDa Foam Protein antibodies useful in immunoassays for the analysis of 17 kDa Foam Protein content of a sample, and immunoassay kits including the antibodies, and optionally 17 kDa Foam Protein standards.
- Products of the invention include foaming products, such as beverages which foam on pouring.
- Preferred products of the invention include brewed and fermented products, in particular, beer, supplemented with enhanced amounts of 17 kDa Foam Protein and having improved foam quality characteristics such as improved foam potential, foam stability, and foam half-life.
- foam quality is enhanced by supplementation of 17 kDa Foam Protein.
- a product may include an amount of 17 kDa Foam Protein naturally and under normal processing conditions
- the method and products of the invention include an additional amount of 17 kDa Foam Protein, supplementing the amount normally present, and resulting in an enhanced amount of the 17 kDa Foam Protein in the product.
- Such supplementation is achieved by adding purified and isolated 17 kDa Foam Protein to the product during its manufacturing steps, or by providing raw materials (for example, barley or wheat grain or yeast) that contain or produce enhanced amounts of 17 kDa Foam Protein.
- a foaming product is manufactured from raw materials such as barley or wheat grain or yeast, which raw materials are transformed with a supplemental nucleic acid sequence encoding 17 kDa Foam Protein.
- foam quality is enhanced by supplementation with a combination of 17 kDa Foam Protein and LTP-1 protein.
- Figure 1 is a diagrammatic representation of the structure of the 17 kDa Foam Protein polypeptide showing predicted disulfide bridges and protein domains A, B, C, and D.
- Figure 2A is a SDS-poiyacrylamide gel showing 17 kDa Foam Protein purified from beer (lane C).
- Figure 2B is a Western blot showing selective reactivity of anti-17 kDa Foam Protein antibody with the isolated and purified protein from beer (lane C).
- Figure 3 is a diagram showing the distribution of 17 kDa protein between flotate and remanent during repeated flotations in a foam tower.
- Figure 4 is a graph showing the effect of removing 17 kDa protein from lager beer.
- Figure 5 is a plasmid map of a self-replicating yeast expression plasmid carrying the coding sequence of 17 kDa Foam Protein.
- Figure 6 is a plasmid map of a yeast integration plasmid carrying the coding sequence of 17 kDa Foam Protein.
- Figures 7A-7C are graphs showing the relationship between foam half-life and the total amount of 17 kDa Foam Protein and foam-type LTP1 in 50 Danish lager beers at different carbonization levels (g CO 2 /liter): 4.8-5.0 (A); 5.1- 5.3 (B); 5.4-5.6 (C).
- Figure 8 is a Western blot of barley, rye and wheat extracts probed with anti-17 kDa Foam Protein (barley) antibody and showing antibody recognition of components in wheat and rye having approximately the same molecular mass (17 kDa).
- barley Foam Protein
- Figure 9 is a diagram showing a barley transformation cassette carrying the coding sequence of the 17 kDa Foam Protein.
- the present invention includes an isolated and purified 17 kDa Foam Protein having foam-enhancing properties, and useful in the production of foaming products, including beer.
- the invention further includes nucleic acid sequences encoding 17 kDa Foam Protein, anti-17 kDa Foam Protein antibodies, and assays for the detection and quantitation of 17 kDa Foam Protein in a sample.
- Methods of the invention include methods for the enhancement of foam quality in a foaming product, and methods for the production of a foaming product, particularly beer, having a content of 17 kDa Foam Protein that is enhanced over the amount of 17 kDa Foam Protein naturally present in the product.
- the content of 17 kDa Foam Protein, and hence the foam quality of a product is enhanced by adding purified 17 kDa Foam Protein directly to the product during processing steps, and/or by providing raw materials genetically engineered to produce increased amounts of 17 kDa Foam Protein.
- a combination of enhanced 17 kDa Foam Protein and LTP-1 is used to enhance foam quality.
- 17 kDa Foam Protein A novel protein isolated from beer foam, first wort, barley or rye having a molecular weight of approximately 17 kilodaltons (kDa) and having foam enhancing properties as described below.
- Figure 1 shows a diagrammatic representation of the predicted 2-dimensional structure of the 17 kDa Foam Protein. While the amino acid sequence set forth in Tables 1 and 2 (SEQ ID NOS: 10 and 12) define one embodiment of the 17 kDa Foam Protein as obtained from beer foam, first wort, and barley, it is anticipated that 17 kDa Foam Proteins (homologues) having similar foam enhancing properties and homologous amino acid sequences will be similarly isolated from other grains by conventional methods.
- 17 kDa Foam Protein includes foam enhancing proteins derived from cereal grain and having the following characteristics of primary structure useful for purposes of identification:
- a molecular mass of about 17 kDa that is, approximately 15 to 20 kilodaltons (kDa)
- a primary amino acid sequence which can be aligned with distinct homology to the non-repetitive C-terminal domain of the sulfur-rich prolamin storage proteins found in cereals. More specifically, a primary sequence showing significant homology (e.g., greater than 25%) to the C-terminal domain of the monomeric ⁇ -type prolamins (such as ⁇ -gliadin in wheat and ⁇ -hordein of barley).
- the 17 kDa foam proteins are distinguished from these latter ⁇ -type prolamins by the lack of an N-terminal proline- and glutamine-rich domain composed of degenerate pentapeptide repeats;
- the 17 kDa foam proteins of the invention can also be identified by its cross-reactivity with anti-17 kDa foam protein antibodies raised against the purified 17 kDa protein purified from barley.
- 17 kDa foam protein can be purified from cereal grain with the use of 17 kDa specific antibodies for identification purposes.
- the 17 kDa foam proteins are members of a newly identified class of storage polypeptides ( ⁇ -type) present in cereal grain, belonging to the prolamin storage protein family. As such, they are found in the endosperm tissue of mature cereal grain and are synthesized during grain development.
- Foam Enhancing Properties As described more fully in the Examples below, 17 kDa Foam Protein, when added to a product such as water, milkshakes, soft drinks, alcopops or beer, causes the product to have enhanced foam quality. Parameters of foam quality that are enhanced include foam potential (P), foam stability (S), and foam half-life (F), as described more fully below.
- P foam potential
- S foam stability
- F foam half-life
- Nucleic Acid Sequences Encoding 17 kDa Foam Protein Nucleic acid sequences encoding 17 kDa Foam Protein were determined by methods described more fully in the Examples below. The nucleic acid sequence of an isolated barley cDNA and its deduced amino acid sequence combined with the determined sequence of the purified protein are shown in Table 1. Nucleotides 1-57 are back-translated from the determined amino acid sequence, using the codon usage bias of the barley 1-3,1-4 ⁇ -glucanase as described by Jensen et al., 1996 PNAS USA 93:3487-3491. A genomic nucleic acid sequence encoding barley 17 kDa Foam Protein and its deduced amino acid sequence is shown in Table 2.
- the deduced amino acid sequence of the 17 kDa Foam Protein encoded by the cDNA and genomic sequences show close homology, but are not identical.
- the given 1336 nucleotide sequence comprises a 522 nucleotide sequence encoding the precursor 17 kDa Foam Protein polypeptide and 674 and 140 nucleotides of 5' and 3' flanking sequences, respectively.
- the 3' flanking sequence contains consensus sequences for three polyadenylation signals (AATAAA).
- the deduced amino acid sequence of the precursor 17 kDa Foam Protein is predicted to have a 19 amino acid signal peptide sequence.
- nucleic acid libraries including genomic DNA and cDNA libraries constructed from a cereal plant, using sequence-specific primers based on the nucleotide sequence of the barley or wheat 17 kDa Foam Protein genes, or alternatively using degenerate primers back- translated from the determined deduced amino acid sequence of 17 kDa Foam Protein from wheat or barley;
- the cDNA or genomic sequence may be identified in a library constructed from a cereal plant by screening the library with a barley cDNA encoding 17 kDa Foam Protein (for example, that shown in Table 1) as a probe, using standard hybridization conditions (5xSSC, 5x Denhardts solution, 0.5% SDS at 65°C) followed by washing at increasing stringency, with a final 30 minute wash at high stringency (65°C in 0.2% SSC, 0.5% SDS).
- homologs As discussed above, a 17 kDa Foam Protein homolog is defined to include proteins derived from cereal plants having the functional and structural characteristics of the described wheat or barley 17 kDa Foam Proteins. Homologous nucleic acid sequences hybridize to the described nucleic acid sequences encoding barley and wheat 17 kDa Foam Protein, under standard and stringent hybridization conditions, for example, those recited above. Homologous amino acid sequences contain the characteristics of primary structure listed above.
- nucleic acid sequence encoding 17 kDa Foam Protein which contains codons that are modified according to optimal codon frequencies for a particular cellular host. For example, modification for expression in yeast is preferred for production of enhanced 17 kDa Foam Protein in yeast, using known preferred codon frequencies for yeast.
- Redundancy in the genetic code permits variation in the gene sequences shown in Tables 1, 2 and 4.
- specific codon preferences are recognized for a specific host such that the disclosed sequence can be adapted as preferred for the desired host. For example, rare codons having a frequency of less than about 20% in known sequences of the desired host are preferably replaced with higher frequency codons.
- Additional sequence modifications are known to enhance protein expression in a cellular host. These include elimination of sequences encoding spurious polyadenylation signals, exon/intron splice site signals, transposon-like repeats, and other such well characterized sequences which may be deleterious to gene expression.
- the G-C content of the sequence may be adjusted to levels average for a given cellular host, as calculated by reference to known genes expressed in the host cell. Where possible, the sequence is modified to avoid predicted hairpin secondary mRNA structures.
- the genomic sequence may additionally be modified by the removal of introns.
- the nucleic acid sequence encoding the 17 kDa Foam Protein is delivered to host cells, including yeast and plant cells, for transient transfections or for incorporation into the cells by known methods.
- the gene is used to stably transform plant cells for expression of the protein in vivo.
- the gene containing the coding sequence for the 17 kDa Foam Protein may be attached to regulatory elements needed for the expression of the gene in a particular host cell or system.
- regulatory elements include, for example, promoters, terminators, and other elements that permit desired expression of the protein in a particular plant host, in a particular tissue or organ of a host such as starchy endosperm, aleurone or embryo tissues of the barley kernel, during grain development or germination or in response to a particular signal.
- the 17 kDa Foam Protein gene may additionally be attached to a regulatory signal peptide directing its expression into the secretory pathway within the cell.
- the 17 kDa Foam Protein gene coding sequence is attached to regulatory sequences directing its expression into the secretory pathway within the starchy endosperm of the developing barley endosperm.
- the protein is also preferentially adapted for production in yeast.
- the isolated nucleic acid sequence of the invention can be incorporated into DNA constructs and used to transform or transfect a host cell.
- DNA vectors can be used, depending on the host cell and desired expression.
- suitable vectors include, but are not limited to, self-replicating or integration plasmids suitable for expression in prokaryotic or eukaryotic cells.
- a typical gene construct includes a promoter, the coding sequence of interest, and a terminator sequence coupled in operative association. Additional known regulatory elements can also be included in the construct.
- Suitable gene constructs for the stable transformation of host cells include those having constitutive promoters such as the Ubi 1 gene promoter (Christensen, et al., 1992, Plant Mol. Biol, 18: 675-689) driving expression of selectable markers such as the phosphinothricin acetyl transferase gene (bar) (De
- the plasmid can include other gene sequences such as resistance genes (required for the selection and amplification of host transformed cells), reporter genes or other elements.
- resistance genes Required for the selection and amplification of host transformed cells
- reporter genes reporter genes or other elements. Examples of suitable plant transformation selection systems for cereals or other plants are described by Yoder and Goldsbrough, 1994, Bio/Technology, 12: 263-267, and Tingay, et al., 1997, 77ze Plant Journal 11: 1369-1376 are incorporated herein by reference.
- a DNA construct of the invention includes a promoter sequence which may be a "homologous” or “heterologous” promoter.
- a heterologous defines a nucleic acid sequence not normally found in the genome associated with the 17 kDa Foam Protein-expressing gene.
- a heterologous sequence is one derived from a different cell type, different plant species, different organism, or one normally associated with a different gene.
- a heterologous promoter is one which does not drive transcription of the 17 kDa Foam Protein-expressing gene in its natural, non-transformed genome.
- a "homologous" promoter is one normally associated with the 17 kDa Foam Protein gene.
- a promoter is a DNA sequence that directs the transcription of a structural gene. Typically, a promoter is located in the 5' region of a gene, proximal to the transcriptional start site. A promoter may be inducible, increasing the rate of transcription in response to an agent, or constitutive, whereby the rate of transcription is not regulated by an inducing agent. A promoter may be regulated in a tissue-specific or tissue-preferred manner, such that it is only active in transcribing the operably linked coding region in a specific tissue type or types, for example, plant seeds, leaves, roots, or meristem.
- An heterologous promoter may initiate transcription of an operably linked gene coding sequence at an earlier time or developmental stage in a given tissue, than initiated by the native promoter of the same gene. Within a given host cell or tissue, certain promoters may drive transcription more strongly, resulting in a higher accumulation of transcript, thereby enhancing synthesis of the gene product.
- a promoter useful in the invention is operably linked to a nucleotide sequence encoding 17 kDa Foam Protein such that transcription of the 17 kDa Foam Protein sequence is driven by the promoter.
- the promoter is operably linked to a nucleotide sequence encoding a signal peptide, which in turn is operably linked to a sequence encoding the mature 17 kDa Foam Protein.
- promoters can be used to express the 17 kDa Foam Protein gene in a host cell.
- tissue-specific promoter which drives gene expression in endosperm tissue of developing grain.
- suitable endosperm specific promoter sequences include the promoters of the following genes: Bl hordein gene ( ⁇ hor2-4, GenBank Ace No: X87232), ⁇ -hordein gene ( ⁇ hor ⁇ -1, GenBank Ace No: XI 3508), C hordein gene ( ⁇ hor 1-14, GenBank Ace No: M36941 and ⁇ hor 1-17, GenBank Ace No: X60037); D hordein gene (phor 3-1, GenBank Ace No: X84369); ⁇ -amylase gene ( ⁇ -amyl, GenBank Ace No: D63574) and protein Z gene (Pazl, GenBank Ace No: X51726).
- Additional regulatory elements include terminators, polyadenylation sequences, and nucleic acid sequences encoding signal peptides that permit localization within a plant cell or secretion of the protein from the cell.
- Such regulatory elements include, but are not limited to, 3' termination/polyadenylation regions such as those of the Agrobacterium tumefaciens nopaline synthase (nos) gene (Bevan, et al, 1983, Nucl.
- Suitable methods include chemical transfection methods such as the use of calcium phosphate, microorganism-mediated gene transfer such as transfection using an Agrobacterium-mediated transfection system (Horsh, et al., 1985, Science, 227:1229-31), electroporation, micro-injection, and biolistic bombardment.
- chemical transfection methods such as the use of calcium phosphate
- microorganism-mediated gene transfer such as transfection using an Agrobacterium-mediated transfection system (Horsh, et al., 1985, Science, 227:1229-31), electroporation, micro-injection, and biolistic bombardment.
- Agrobacterium-mediated Transformation The most widely used method for introducing an expression vector into plants is based on the natural transformation system of Agrobacterium.
- A. tumefaciens and A. rhizogenes are plant pathogenic soil bacteria which genetically transform plant cells.
- the Ti and Ri plasmids for A. tumefaciens and A. rhizogenes, respectively, include genes responsible for this genetic transformation. See, for example, Kado, 1991, Crit. Rev. Plant Sci. 10:1.
- a generally applicable method of plant transformation is microprojectile-mediated transformation, wherein DNA is carried on the surface of microprojectiles measuring about 1 to 4 ⁇ m in diameter.
- the expression vector is introduced into plant tissues with a biolistic device that accelerates the microprojectiles to speeds of 300 to 600 m/s, sufficient to penetrate the plant cell walls and membranes.
- Electroporation of protoplasts and whole cells and tissues has also been described. See, for example, D'Halluin, et al., 1992, Plant Cell 4:1495-1505; and Spencer et al., 1994, Plant Mol. Biol. 24:51-61.
- 17 kDa Foam Protein can be commercially produced by expression in yeast, either laboratory yeast (e.g.,Saccharomyces cervisiae) or in brewer's yeast (e.g., Saccharomyces carlsbergensis).
- yeast either laboratory yeast (e.g.,Saccharomyces cervisiae) or in brewer's yeast (e.g., Saccharomyces carlsbergensis).
- yeast either laboratory yeast (e.g.,Saccharomyces cervisiae) or in brewer's yeast (e.g., Saccharomyces carlsbergensis).
- yeast signal peptide e.g., Saccharomyces carlsbergensis
- yeast expression vector for example under the control of an inducible promotor, and used to transform yeast cells.
- a 17 kDa Foam Protein expression cassette including the 17 kDa Foam Protein coding sequence, yeast signal peptide coding sequence, and promoter is stably integrated into the yeast genome.
- yeast cells containing the 17 kDa Foam Protein expression cassette during fermentation 17 kDa Foam Protein can be directly secreted into the wort.
- An example of one such expression system is more fully described below in Example 17.
- 17 kDa Foam Protein secreted into the yeast cell growth medium can also be isolated and purified as described in the Example 16 and 17 below, and added to the product during one or more steps in the brewing process.
- Suitable host cells for transformation with the nucleic acid sequence of the invention or its coding sequence include cells that will benefit from the expression of enhanced amounts of 17 kDa Foam Protein, and cells that are useful as raw materials for the production of foaming products.
- Host cells may be adapted for the production, isolation and purification of large amounts of 17 kDa Foam Protein polypeptide.
- Preferred host cells include plant cells, such as barley or other cereal grains, and yeast cells, that are useful in a commercial process to produce foaming products, such as beer.
- Host cells such as bacterial, yeast, or eukaryotic cell lines are transformed with the nucleic acid sequence of the invention such that the transformed cells produce enhanced levels of active 17 kDa Foam Protein.
- the active protein is then added to a brewing mixture, for example, to malt, malt extract, wort, or clarified product to enhance final product foam quality.
- the nucleic acid sequence encoding 17 kDa Foam Protein is used to transform plants whose grain is used in fermentation processes, including barley, wheat, sorghum and other cereals.
- Other host cells including bacteria, yeast, and eukaryotic cell lines are transformed with the nucleic acid sequence of the invention, and used to produce an 17 kDa Foam Protein that can be added to the system during beer production.
- transgenic plant cells, callus, tissues, kernels, and transgenic plants are tested for the presence of the 17 kDa Foam Protein-expressing gene by DNA analysis (Southern blot or PCR), for expression of the gene by immunoassay (ELISA or Western blot), or for functional protein activity by a foam activity assay. Examples of some such conventional methods are shown in the Examples below.
- transgenic plant cells or tissue can be assayed for the presence of 17 kDa Foam Protein mRNA transcripts by hybridization to 17 kDa Foam Protein DNA probes.
- the cDNA sequence encoding the barley 17 kDa Foam Protein [Sequence ID No.9] is a useful hybridization probe for identifying the presence of 17 kDa Foam Protein mRNA in a test sample.
- Such probes are preferably about 10-35 consecutive nucleic acids, but the size may be larger.
- Transcripts from plant tissue transformed with a construct comprising the 17 kDa Foam Protein gene fused to heterologous 5 ' or 3' untranslated region (UTR) sequences can be selectively detected and quantitated by RNA-PCR using primers pairs located in the coding region and the 5' or 3' UTR.
- UTR untranslated region
- a 17 kDa Foam Protein gene construct, fused to a heterologous promoter and/or terminator, can be detected in the genome of transformed tissue by PCR using primer pairs located in the 17 kDa Foam Protein coding region and the heterologous promoter or terminator sequences.
- the PCR product can be used as a hybridization probe for Southern blot analysis of genomic DNA from transformed plants. Transformed plants are compared with untransformed plants to distinguish the introduced constructs from the endogenous 17 kDa Foam Protein gene.
- Samples, including transgenic cells, tissue, plants, and foaming products are screened for content of the 17 kDa Foam Protein by immunological assays, including an Enzyme Linked Immunoassay (ELISA).
- ELISA Enzyme Linked Immunoassay
- Polyclonal antibodies used in an ELISA are, for example, generated against the purified 17 kDa Foam Protein or as described below for Example 8.
- ELISA ELISA
- wells of a microtiter plate are coated with anti- 17 kDa Foam Protein antibodies.
- An aliquot of a sample (the antigen) is added in serial dilution to each antibody-coated well.
- Labelled anti-17 kDa Foam Protein antibodies such as biotinylated antibodies, are then added to the microtiter plate.
- the concentration of bound labelled (e.g., biotinylated) antibody is determined by the interaction of the biotin with streptavidin coupled to peroxidase. The activity of the bound peroxidase is easily determined by known methods.
- the amount of 17 kDa Foam Protein in a sample is quantitated with reference to the ELISA performed with pure antigen standards, where the detection range should lie in the range of 0.2 - 10 ng/ml. Any known method for producing antibodies and using such antibodies in an ELISA assay can be used to determine the amount of 17 kDa Foam Protein in samples, and expressed in transgenic plant cells and tissues of the invention.
- Immunoassay Kits are any known method for producing antibodies and using such antibodies in an ELISA assay can be used to determine the amount of 17 kDa Foam Protein in samples, and expressed in transgenic plant cells and tissues of the invention.
- An immunoassay kit of the invention includes an anti-17 kDa Foam Protein antibody.
- the kit also contains 17 kDa Foam Protein standards for quantitative analysis.
- the kit can include other anti-Foam Protein antibodies such as anti-LTPl antibodies and/or additional reference antibodies or standards.
- the invention provides for improvements in the production of foaming products, such as beer. Improvements in beer are particularly in the quality of the beer foam.
- a manufacturing process for the production of beer can include the following processing steps:
- beers are manufactured from grains, including barley grains, which are naturally low in fermentable sugars. Hydrolysis of starch to sugars is needed prior to fermentation with yeasts. To effect this hydrolysis, grains are wetted and allowed to germinate, during which time the germinating kernels produce hydro lytic enzymes (malting). At the end of malting, the malt is kilned and stored. The malt is then ground and suspended in water at the start of mashing, during which the major part of starch hydrolysis occurs to produce the wort. The wort is boiled and separated from insoluble materials. The wort is then fermented, for example by adding yeast to the wort. Fermentation will convert the wort to beer. To clarify and finish the product, insolubles are filtered, and other constituents are added.
- the quality of the foam depends on both the brewing process and the raw materials used.
- the quality of foam is enhanced by supplementing the brewing process with 17 kDa Foam Protein added during one or more processing steps and/or by providing raw materials such as barley grain or brewer's yeast producing enhanced amounts of 17 kDa Foam Protein.
- Danish Lager beer brewed with adjuncts contains about 10-50 mg/1 of 17 kDa Foam Protein.
- the effect of further addition of 17 kDa Foam Protein is dependent on the composition of the beer and the ratio of the beer's foam components. However, in general, addition of about 25 mg/1 or more of 17 kDa Foam Protein is expected to have a beneficial effect on the foam properties of the beer.
- the quality of foam in a foaming product is enhanced by providing enhanced amounts of 17 kDa Foam Protein in combination with enhanced amounts of LTP protein.
- a combination of enhanced amounts of 17 kDa Foam Protein and enhanced amounts of LTP 1 are provided by genetically engineering plants such as barley, rye and wheat to produce high amounts of these Foam Proteins.
- a cereal plant e.g., a barley plant carrying transgenes encoding both LTPl and 17 kDa Foam Protein.
- two independent transgenic lines e.g. barley
- the two lines are crossed to generate and breed lines which are homozygous for both transgenes, thereby producing a plant, e.g. barley plant, providing even greater enhancement of foam potential and stability than achieved by either transgene alone.
- the Head Hunter an opto-electrical foam assay system using digital video image analysis, was used to measure foam potential and foam half-life of small, degassed samples. This system creates foam on 10 ml samples by a short, vigorous, standardized shaking procedure. The decay with time of the foam column generated in this way is then automatically monitored (Haugsted, et al., 1990 Monatsschr. Brauwissenschaft 43:336-339; Haugsted and Erdal, 1991 Proc. 23rd EBC Congress (Lisbon): 449-456).
- the foam potential (P) is the amount of foam formed initially, in ml per ml sample.
- the foam half-life (F) is the time, in seconds, after which the foam column is reduced to half the initial volume.
- foam assays on the Head Hunter were conducted at least in duplicate.
- 150 g of beer is fully converted to foam, and the decay of foam into beer is followed. After an initial lag phase of about 30 seconds, this decay is a first order process (Hallgren, et al, 1991 J. Am. Soc. Brew. Chem. 49:78-86).
- the foam half-life, in seconds, is then determined.
- CO 2 in beer was determined by a titration procedure. Initially, CC ⁇ was absorbed in a carbonate-free solution of sodium hydroxide. Then, CO was liberated again via addition of sulphuric acid and forced into a solution of barium hydroxide of known concentration. After precipitation of barium carbonate, the surplus of barium hydroxide was determined by titration with hydrochloric acid using phenolphtalein as an indicator, and CO 2 in beer was finally calculated from this determination.
- the protein content was determined from amino acid analyses or by the dye binding method of Bradford (Bradford, 916 Anal. Biochem 72:248-254).
- SDS-PAGE and Western blots SDS-polyacrylamide gel electrophoresis (PAGE) was performed after boiling the samples for 5 minutes in NuPAGE sample buffer from Novex supplemented with 10 mM dithiothreitol using a Novex XCell IITM mini cell, NuPAGETM 10% Bis-Tris gels (1.0 mm x 10 wells) and NuPAGE MES-SDS Running Buffer from Novex. Blotting onto nitrocellulose was then performed in the Xcell IITM blot module using the NuPAGETM Transfer Buffer from Novex. After washing with water, the nitrocellulose was incubated 30 minutes with calf serum to block non-specific binding and then incubated overnight with antibodies.
- PAGE SDS-polyacrylamide gel electrophoresis
- the Promega Western blot AP system (Catalogue No. W3930) was then applied to detect specific antibody binding.
- a mixture of nitro blue tetrazolium and 5-bromo-4- chloro-3 -indolyl phosphate was used as color development substrate for alkaline phosphatase.
- Amino acid compositions were determined on an amino acid analyzer (LKB, model Alpha PlusTM) after hydrolysis in 6 M HCI at 110°C for 24 hours in evacuated tubes.
- N-terminal amino acid sequencing was performed on a gas-phase sequence (Applied Biosystems model 470 A), using the program provided by the company.
- the phenylthiohydantoin-labelled amino acids from the sequencer were identified on-line by reversed-phase HPLC using an Applied Biosystems model 120 A phenylthiohydantoin analyzer.
- foam was produced from 15 liters of beer by sparging with nitrogen, as described in S ⁇ rensen, et al., 1993, MBAA Techn. Quart. 30:136-145.
- the foam fraction was diluted with water and reintroduced into the foam tower. Two additional flotations were carried out to get rid of components which were not foam-active themselves but merely carried over with the foam.
- the third flotate was used in the following studies. By gel chromatography on Sephadex G75, the foam fractions were separated according to size into three fractions: a high molecular weight fraction (HMW), a low molecular weight fraction (LMW), and a very low molecular weight fraction.
- HMW high molecular weight fraction
- LMW low molecular weight fraction
- very low molecular weight fraction a very low molecular weight fraction.
- the very low molecular weight fraction consisted of small peptides and carbohydrates, free amino acids, and iso- ⁇ acids.
- Foam analyses in the Head Hunter revealed that the foam active components are present in the HWM and LMW foam fractions, while the very low-molecular weight foam fraction does not contribute to foam formation nor foam stability. When dissolved in water, the HMW foam fraction forms a low but most stable foam, while the LMW foam fraction provides a very high foam potential.
- the HMW foam fraction contains mainly carbohydrate (90%) but also some protein Z, a barley albumin. Foam measurements on protein Z isolated from beer showed that protein Z creates a low but very stable foam when dissolved in water. Further, protein Z isolated from beer has a stabilizing effect on the foam created by other proteins.
- protein Z was distributed with approximately 1/3 in the first flotate and 2/3 in the remanent. In the following flotations, most of protein Z from the beer remained in the remanent. Thus, protein Z does not concentrate in the foam upon foaming of beer.
- Protein Z has also been purified from malt and antibodies have been raised against this protein. Based on these antibodies a sandwich ELISA for the quantification of protein Z has been established. Using these antibodies, an affinity column directed towards protein Z has been synthesized and used for selective removal of protein Z from beer. Removal of protein Z does not influence the foam potential, but affects the foam stability, depending on the composition of the beer.
- the LMW foam fraction consists of 10% carbohydrate and 90% protein.
- a major component in LMW foam is the protein Lipid Transfer Protein 1 (LTPl), a barley protein with a molecular weight of 10,000.
- LTPl Lipid Transfer Protein 1
- the LMW foam fraction also contains substantial amounts of other peptides of which the major part can be separated from LTPl by ion exchange chromatography.
- LTPl from foam forms a very high foam which is not particularly stable.
- Foam-LTPl also increases foam potential when dissolved in beer, the effect, however, being not as pronounced as in water since beer already contains foam positive agents.
- LTPl has also been purified from barley (barley-LTPl), and foam measurements have shown that foam-LTPl is considerably more foam active than is barley-LTPl . It was, therefore, of interest to compare the two varieties and investigate when the transformation of LTPl into a more foam active form takes place.
- the LMW foam fraction also contains substantial amounts of other peptides of which the major part can be separated from LTPl by ion exchange chromatography. Amino acid analysis of this pool, "Pool 1", showed high concentrations of proline and glutamate/glutamine, indicating that it contains substantial amounts of hordein peptides. When dissolved in water, Pool 1 contributes to foam potential as well as foam stability. Pool 1 is also able to increase foam potential when dissolved in beer.
- 17 kDa Foam Protein was purified from 5 liters of beer by addition of ammonium sulfate to 55% saturation. After 16 hours at 4° C, the suspension was centrifuged and the precipitate was dissolved in water and dialyzed in a SpectraporTM membrane against water. The dialysate was passed through a 270 ml SP-SepharoseTM column equilibrated with 20 mM sodium acetate, pH 4.5. The run-through fraction from this column was adjusted to pH 3.9 by addition of HCI and the ionic strength was reduced to 0.03 mS by addition of water.
- the resulting fraction was subjected to ion exchange chromatography on a 270 ml SP- SepharoseTM column equilibrated with 5mM sodium formate, pH 3.9.
- ELISA revealed the 17 kDa Foam Protein to be eluted by a linear gradient from 0 to 0.25 M NaCl.
- Fractions containing the 17 kDa Foam Protein were concentrated by vacuum evaporation and applied to a 350 ml SephadexTM G50 column equilibrated with 20mM sodium acetate, 100 mM sodium chloride, pH 4.9.
- the resultant fractions were analyzed by ELISA and those containing the 17 kDa Foam Protein were pooled, dialyzed against water and lyophilized.
- 17 kDa Foam Protein was isolated from 2 kg barley flour (Alexis) by extraction with 10 L water at 45°C for 1 hour. The mixture was centrifuged and ammonium sulfate (50% saturation) was added to the supernatant to precipitate protein. After 16 hours at 4°C, the suspension was centrifuged and the precipitate was dissolved in water and dialyzed in a Spectrapor membrane against water. 17 kDa Foam Protein was purified from barley essentially as described above for purification from beer in Example 2.
- 17 kDa Foam Protein was isolated from first wort from a production scale mashing (Carlsberg Pilsner) using the purification procedure described above for Example 2. On SDS-PAGE, the preparation showed a distinct double band of 17-18 kDa.
- 17 kDa Foam Protein isolated from barley and beer as described above was subjected to N-terminal sequencing.
- 17 kDa Foam Protein from barley was sequenced 40 cycles while 17 kDa Foam Protein from beer was found to be N- terminally blocked.
- 17 kDa Foam Protein contains 7 methionyl residues corresponding to 8 cyanogen bromide fragments. After chemical cleavage with cyanogen bromide, five of these fragments were isolated and sequenced and the sequence showed homology with that of the 17 kDa Foam Protein encoded by the cDNA and genomic clones shown in Tables 1 and 2.
- the amino acid sequence of each of these fragments is indicated in the sequence Table 1 by underlining, and is listed below.
- the nucleotide sequence of the barley gene coding for the 17 kDa Foam Protein was determined from a cDNA clone generated by reverse transcription and amplification techniques (RT-PCR).
- the cDNA clone was selectively amplified from a total RNA population isolated from developing barley endosperm tissue cv Alexis, 20 days after anthesis, as described by Rechinger, et al. 1993, Theor. Appl. Genet. 85:829-840.
- the mRNA in the RNA population was reverse transcribed with a poly dT primer having a BamHl restriction site sequence at the 5 'end (5' ATGGATCCT ⁇ 3') [SEQ ID NO: 6].
- the reaction mixture (20 ⁇ l) comprising 1 ⁇ g total RNA, 1 ⁇ M poly dT primer, 1 mM deoxynucleoside triphosphates, 28U RNasin (Promega) and 20U M-MuLV reverse transcriptase (Boehringer Mannheim) in a buffer supplied by the manufacturer, was incubated at 40°C for 30 minutes.
- the first strand cDNA was amplified with a sequence-specific, but degenerate primer, based on a determined amino acid sequence located near the N-terminus of the 17 kDa Foam Protein (PQQQMN) [SEQ ID NO: 7], having a BamHl restriction site sequence at the 5 'end (5 'ATGGATCCICAICAICAIATGAA 3') [SEQ ID NO: 8] ("I" denotes the degeneracy).
- PQQQMN 17 kDa Foam Protein
- the reaction mixture (lOO ⁇ l) comprised 4 ⁇ l first strand cDNA reaction mixture, 0.2 ⁇ M sequence-specific and polydT primers, 0.2 mM deoxynucleoside triphosphates and 2.5U AmplitaqTM DNA polymerase (Perkin Elmer) in a buffer supplied by the manufacturer.
- the cDNA was amplified in a Perkin Elmer Thermocyler 480 with 30 heating cycles (95°C for 1 minute / 50°C for 1 minute) and then analysed by agarose gel electrophoresis. A cDNA fragment of approximately 580 nucleotides was isolated, cloned into a plasmid vector and its nucleic acid sequence was determined with an AmpliCycleTM Sequencing Kit (Perkin Elmer). The determined and back- translated nucleic acid sequence [SEQ ID NO: 9] and the determined and deduced amino acid sequence [SEQ ID NO: 10] are shown below in Table 1.
- Nucleotides 1 - 57 were back-translated from the determined N-terminal amino acid sequence of the 17 kDa Foam Protein using the codon bias of the barley 1-3,1-4 ⁇ -glucanase according to Jensen et al., 1996 supra.
- the deduced amino acid sequence encoded by the partial cDNA clone shows complete homology with the sequence of N-terminal and cyanogen bromide peptide fragments determined for the purified 17 kDa foam polypeptide, confirming that the isolated cDNA encodes the 17 kDa Foam Protein.
- Underlined sequences in Table 1 indicate the sequences of the cyanogen bromide fragments.
- PCR primers used to amplify the clone are indicated above the sequence. * Denotes stop codon.
- the cDNA clone encoding the 17 kDa Foam Protein was used to screen a commercially available barley genomic library (Lambda Fix II Barley cv Igri Genomic Library from Stratagene, Catalog No: 946104) in order to obtain the genomic gene sequence.
- barley genomic library Lambda Fix II Barley cv Igri Genomic Library from Stratagene, Catalog No: 946104
- three positive plaques were identified out of 400,000 plaques.
- One characterized lambda genomic clone contained a hybridizing
- This genomic sequence contains the complete coding sequence for a precursor form of the 17 kDa Foam Protein.
- the deduced amino acid sequence of this precursor 17 kDa Foam Protein (SEQ ID NO: 12) is predicted to comprise a 19 amino acid signal peptide with a signal peptide cleavage site between Ala 19 and Gin 20, according to the signal peptide algorithm developed by Nielsen, et al., 1997 Protein Engineering 10: 1-6.
- the N-terminal amino acid of the determined mature 17 kDa Foam Protein amino acid sequence is Leu 21.
- the actual signal peptide cleavage site is Gln20 iLeu21, or alternatively that the N-terminal Gln20 is cleaved off post-translationally to give the amino acid sequence of a mature 17 kDa Foam Protein.
- the deduced amino acid sequences of the 17 kDa Foam Proteins encoded by the genomic and cDNA clones show close homology, with six amino acid missmatches. These sequence differences may reflect heterogeneity between cultivars or the presence of more than one copy of the gene in the haploid genome.
- the gene 3' flanking sequence of 140 nucleotides contains consensus sequences for three polyadenylation signals.
- the gene 5' upstream sequence of 674 nucleotides contains a TATAA box, shown underlined in Table 2, located 85 nucleotides upstream of the translation start codon.
- An endosperm box (TGTAAAG) followed by a GCN4 box (ATGAGTCAT), shown in bold, located 304 nucleotides upstream of the translation start, are transcription regulatory elements found in the promoters of many cereal endosperm storage protein genes (Muller and Knudsen 1993 The Plant Journal A: 343-355).
- the nucleotide sequence of a wheat gene coding for a homologue of the barley 17 kDa Foam Protein was determined from a genomic DNA fragment amplified by PCR. Wheat grain (Triticum aestivum L.) cv Husar was germinated and grown in the dark for 6 days and the etiolated leaves harvested for the preparation of genomic DNA using a Plant DNA Isolation Kit from Boehringer Mannheim. Wheat genomic DNA (0.5 ⁇ g) was PCR amplified with degenerate sense and antisense oligonucleotide primers based on the deduced amino acid sequence of the barley 17 kDa Foam Protein:
- the genomic DNA was amplified with 2.5 pmol of each primer and AmpliTaqTM DNA polymerase (Perkin Elmer) in a reaction mixture provided by the manufacturer, using a ⁇ touch-down' thermocycling program (95°C for 0.45 minutes, 54°C [ -1°C /cycle ( 40°C) ] for 0.45 minutes and 72°C for 2 minutes for 15 cycles; 95°C for 0.45 minutes, 40°C for 0.45 minutes and 72°C for 2 minutes for 25 cycles; 72°C for 6 minutes).
- PCR product of about 500 nucleotides was isolated, cloned in a pCR 2.1-TOPO plasmid vector (Invitrogen) and sequenced with an AmpliCycleTM sequencing Kit (Perkin Elmer) on an Applied Biosystems 373 DNA sequencer.
- the nucleotide sequence of the amplified genomic DNA was found to encode a homolog of the barley 17 kDa Foam Protein.
- the nucleic acid sequence [SEQ ID NO: 20] and deduced amino acid sequence [SEQ ID NO: 21] of the wheat 17 kDa Foam Protein are shown in Table 4.
- Sequence alignment of the nucleic acids encoding wheat and barley 17 kDa Foam Protein homologs indicates that the wheat amplified genomic fragment, including the primers, encodes the last 2 residues of the predicted signal peptide and extends to within 4 amino acids of the C-terminus of the mature barley 17 kDa Foam Protein sequence.
- the high degree of sequence homology between the wheat and barley 17 kDa Foam Protein homologues is consistent with recognition of a wheat 17 kDa polypeptide by the anti-barley 17 kDa Foam Protein antibodies described in Example 19.
- 17 kDa Foam Protein was isolated from beer and from barley as described for Examples 2 and 3. Head Hunter foam assays were performed on the isolated proteins dissolved in distilled water at concentrations of 0.25 or 0.50 mg/ml. The data shown below in Table 5 demonstrates that the protein isolated from beer was able to produce a high and stable foam, whereas the protein isolated from barley produced only a moderate foam with very little stability. The foam capacity of the barley-form of 17 kDa was only slightly affected by the presence or absence of nicks in the peptide chain. Table 5
- Foam assays were also performed on beer supplemented with 17 kDa Foam Protein that had been isolated from beer.
- the 17 kDa Foam Protein was supplemented either alone or in combination with LTPl that had been isolated from beer foam (Bech, et al., 1995, supra).
- a lager beer, Carlsberg Pilsner, naturally containing 30 mg/1 of the foam-type of LTPl and 25 mg/1 of 17 kDa Foam Protein was diluted 1 : 1 with a solution of 4% ethanol in water and used as basis for these experiments.
- the rabbits received 250 ⁇ g LMW foam preparation at each injection.
- a volume of 20 ml serum was obtained from each animal approximately two months after the first injection, and then at monthly intervals. Serum obtained from the second bleeding of one of the animals (batch no. 1897), was used throughout the experiments described below.
- Antibodies of the immunoglobulin G class were purified from other serum components by affinity chromatography on Hi-Trap Protein A- Sepharose (Pharmacia, Uppsala, Sweden) according to the manufacturer's instructions.
- the pool of antibodies thus obtained also contained antibodies recognizing LTPl of the foam- type, which is a prominent Foam Protein in beer.
- Antibodies recognizing LTPl were removed from the IgG pool by affinity chromatography on a small column containing LTPl of the foam-type covalently attached to CNBr-activated Sepharose according to the manufacturer's instructions. When the remaining antibodies were used in Western blots of beer protein, only 17 kDa Foam Protein was stained as a distinct double band (See Figure 2B, lane A foam-LTP-1; lane B, beer; lane C, 17 kDa Foam Protein from beer). The antibodies specific to 17 kDa Foam Protein were used as coating reagent in ELISA assays, performed as described below for Example 10. Biotinylated antibodies used in this assay were prepared using the complete IgG fraction of serum no. 1897.
- a small affinity column was prepared by covalently coupling antibodies specific to 17 kDa Foam Protein to CNBr-activated Sepharose
- the assay was performed in polystyrene wells arranged in strips of twelve, and the strips were placed in frames each containing eight strips (Nunc Immuno Module C12 MaxisorpTM from Life Technologies, Denmark).
- the specific 17 kDa Foam Protein antibodies were diluted to
- PBS 10 phosphate buffered saline: 10 mM sodium phosphate pH 7.3, 150 mM NaCl. 200 ⁇ l aliquots were added to each well and incubated at 4°C for 16-20 hours. After this, the wells were emptied and washed 5 times with PBST (PBS 10 supplemented with 0.01% Tween 20) (Merck, Darmstadt, Germany). Residual binding sites on the polystyrene surface were then blocked by adding 200 ⁇ l
- BSA/PBST PBS10 supplemented with bovine serum albumin (BSA), 1 g/1, and 0.05% Tween 20
- BSA bovine serum albumin
- Tween 20 bovine serum albumin
- step 3 biotinylated antibodies were diluted to 1 ⁇ g/ml in BSA/PBST. 200 ⁇ l aliquots were incubated in the wells for 10 minutes at ambient temperature. After this, the wells were emptied and washed.
- step 4 a conjugate of streptavidin and horseradish peroxidase (SIGMA) was diluted to 0.25 ⁇ g/ml in BSA/PBST. 200 ⁇ l aliquots were incubated in the wells for 10 minutes at ambient temperature. After this, the wells were emptied and washed.
- step 5 a substrate was prepared containing 3.3 ',5.5'- tetramethylbenzidine (TMB), 100 ⁇ g/ml, and H O , 0.015%o, in phosphate-citrate buffer pH 5.0. 200 ⁇ l aliquots were incubated in the wells for 5 minutes at ambient temperature.
- TMB 3.3 ',5.5'- tetramethylbenzidine
- H O 0.015%o
- Each series of analyses included a set of 17 kDa Foam Protein standards prepared from "Pool 1", a fraction of beer foam rich in this protein.
- Pool 1 a fraction of beer foam rich in this protein.
- One preparation of Pool 1 obtained from a commercial lager beer (Carlsberg Pilsner), was used in the experiments described below.
- the total protein content in this Pool 1 was determined by amino acid analysis, and standards were prepared in the range 0-33 ng Pool 1 protein/ml.
- the final assay was highly specific to 17 kDa Foam Protein. Only very slight reactions with other proteins purified from beer, barley or malt could be observed (See Table 7).
- this protein was purified from malt essentially as described in the literature (Hejgaard, 1982 Physiol. Plant 54:174-182) and used for immunization of rabbits using the methods described for Example 9.
- a non-competitive ELISA procedure of the sandwich-type was then established for protein Z, essentially as described for 17 kDa Foam Protein in Example 10.
- the preparation of protein Z used for immunization was also used as standard in the ELISA assays.
- a set of 22 beers varying in original gravity from 7.3 to 15.9 and with widely different levels of beer proteins were used for testing the correspondence between the two methods of quantification. Some beers were brewed with 30-40% maize grits as adjunct, and some were all-malt beers.
- the ELISA results agreed well with the quantifications based on affinity chromatography. The slope of straight lines obtained as best fit when plotting analytical values obtained by affinity chromatography vs. values obtained by ELISA were 0.78 for the barley-type LTP, 0.90 for foam-type LTP and 0.82 for protein Z. Thus, affinity chromatography gave slightly lower results than ELISA for all three proteins, probably due to a slight loss of material during the chromatographic procedure.
- Foam was produced from 15 liters of lager beer by sparging with nitrogen gas in a foam tower overnight at a rate of 450 ml/minute (S ⁇ rensen et al., 1993 supra). The nitrogen gas was saturated with water vapor before introduction into the foam tower. After collapse, the foam collected at the outlet was diluted to the original volume with distilled water and reintroduced into the foam tower. A second and a third flotation was performed as described above. After each flotation step, aliquots of the foam, termed the flotate, and of the remaining unfoamed liquid, termed the remanent, were collected for analysis.
- the content of 17 kDa Foam Protein in flotates and remanents and in the original lager beer was determined by ELISA assays performed as outlined in Example 10. During the first flotation, at least 75% of the 17 kDa Foam Protein found in the beer was transferred to the foam, whereas only 25% or less remained in the unfoamed liquid. During repeated flotations, only very small amounts of 17 kDa Foam Protein were found in the remanent, whereas the 17 kDa Foam Protein found in foam from a flotation was transferred almost quantitatively to a subsequent foam fraction (see Figure 3).
- Example 13 Selective Removal of 17 kDa Protein Severely Reduces Foam Potential
- a small affinity column was prepared by covalent coupling of antibodies specific to 17 kDa Foam Protein to CNBr-activated Sepharose according to the manufacturer's directions.
- a volume of 90 ml of a standard lager beer from a production plant (Carlsberg Pilsner) was repeatedly passed through the column, and the content of 17 kDa Foam Protein, foam-type LTP, barley-type LTP and protein Z was determined after each passage of the column by means of ELISA assays.
- the foaming capacity of the sample was determined after each passage by use of HeadHunter equipment.
- Example 14 Content of 17 kDa Foam Protein in Beer and Correlation to Foam Half-Life
- the content of 17 kDa Foam Protein in 50 Danish lager beers was determined by means of the ELISA procedure described in Example 10.
- the beers were obtained from a variety of Danish breweries and included both all-malt types and beer brewed with maize grits as adjunct. They were collected during the first three months of 1997 and were at that time all within the day of latest purchase. The samples were further analyzed by ELISA procedures for the foam-type of LTPl, the barley-type of LTPl and for protein Z as described above for Example 10.
- the content of CO 2 was determined as described in the section on analytical procedures.
- the foam half-life (F) of the bottled beer was determined on the Foam Stability Analyzer.
- the average concentration of 17 kDa Foam Protein and other beer proteins in 50 Danish lager beers is shown below in Table 8.
- the content of CO 2 in beer is known to influence foam half-life determinations made on the Foam Stability Analyzer. Therefore, the beers were grouped according to their content of CO 2 before investigating if any relationships existed between foam half-life and content of beer proteins.
- the foaming properties of a beer may be enhanced by the use of barley malt, genetically engineered to contain an elevated content of the 17 kDa Foam Protein, as a raw material in the beer brewing process.
- the 17 kDa Foam Protein is found in endosperm of mature grain and as a member of the hordein storage protein family is synthesized during grain development.
- the accumulation of 17 kDa Foam Protein in the developing endosperm is enhanced, for example, by the insertion of additional copies of the 17 kDa Foam Protein gene into the barley genome, under the transcriptional control of its native promoter or, alternatively, under the control of any one of the various previously characterized endosperm specific promoters, e.g.
- the sequence encoding the mature 17 kDa Foam Protein is cloned downstream of the promoter of the D hordein gene (Hor3, GenBank Accession number: X84368), as shown in Figure 9. Since proteins homologous in sequence to 17 kDa Foam Protein are found in wheat (Table 4) and in rye (see Example 19, below) (Rocher, et al., 1996, Biochem. Biophys. Acta. 1295:13-22), and may be found in other cereals, it is assumed that these homologs could equally be used to enhance the foaming properties of beer.
- the 17 kDa Foam Protein cDNA clone or other probes may be used to screen out gene sequences encoding 17 kDa Foam Protein homologs from cDNA or genomic libraries constructed from cereals such as rye, wheat or rice.
- PCR amplification techniques may be used to amplify homologous 17 kDa Foam Protein gene sequences from genomic DNA prepared from these cereals.
- Similar transformation expression cassettes namely promoter, signal peptide-encoding sequences and terminator, can be used to express transgenes encoding 17 kDa Foam Protein homologues in the developing barley grains or in other cellular hosts.
- the foaming properties of beer may be enhanced by the addition of 17 kDa Foam Protein or its homologues to the wort.
- 17 kDa Foam Protein or a homolog is produced on an industrial scale by expression of the 17 kDa Foam Protein gene in either laboratory yeast (e.g. Saccharomyces cerevisiae), or brewers yeast (e.g. Saccharomyces carlsbergensis).
- yeast e.g. Saccharomyces cerevisiae
- yeast e.g. Saccharomyces carlsbergensis
- the 17 kDa Foam Protein coding sequence, fused to an appropriate sequence encoding a yeast signal peptide is cloned into a self-replicated yeast expression plasmid under the transcriptional control of an inducible promoter and transformed and maintained in yeast under selective pressure.
- the 17 kDa Foam Protein secreted into the yeast growth medium can subsequently be purified according to protocols similar to those described in Example 2.
- the 17 kDa Foam Protein polypeptide expression cassette (yeast promoter + yeast signal peptide coding sequence + 17 kDa Foam Protein coding sequence) can be stably integrated into the yeast genome.
- 17 kDa Foam Protein secreted into the yeast growth medium may similarly be purified as described in Example 2 and subsequently added to the wort. Stable integration of the 17 kDa Foam Protein expression cassette into brewers yeast allows the secretion of the 17 kDa Foam Protein directly into the wort during fermentation.
- FIG. 5 One example of a self-replicating yeast expression vector is shown in Figure 5, which comprises the PRB 1 promoter (derived from the S. cerevisiae PRB 1 gene encoding protease B), the PGK terminator (derived from the S. cerevisiae PGK gene encoding phosphoglycerate kinase) and the mature 17 kDa Foam Protein coding sequence inserted downstream of the sequence encoding the B. macerans (1-3, l-4)- ⁇ -glucanase signal peptide.
- PRB 1 promoter derived from the S. cerevisiae PRB 1 gene encoding protease B
- the PGK terminator derived from the S. cerevisiae PGK gene encoding phosphoglycerate kinase
- the mature 17 kDa Foam Protein coding sequence inserted downstream of the sequence encoding the B. macerans (1-3, l-4)- ⁇ -glucanase signal peptide
- the 17 kDa Foam Protein yeast expression vector is derived from pBl-L-MH(A16-M) (Meldgaard, et al., 1995, Glycoconjugate J. 12: 380-390) using the following cloning steps.
- the plasmid, pBl-L-MH(A16-M) is first linearized with BgM and the site is blunt ended.
- the plasmid is then digested with /JstEII to excise the (1-3, l-4)- ⁇ -glucanase coding sequence, which is then replaced with the 17 kDa Foam Protein coding sequence amplified from the 17 kDa Foam Protein cDNA using the following primers:
- the PCR product is then digested with ifatEII (ifatEII site underlined) prior to the replacement cloning step.
- ifatEII ifatEII site underlined
- the 17 kDa Foam Protein yeast expression vector is transformed into an appropriate Leu- yeast strain and cultivated in fermentors in SC medium without Leu as described by Meldgaard, et al., 1995, supra.
- yeast expression plasmid shown in Figure 5 may be used as a basis.
- the plasmid is restriction digested with EcoRI, and the large fragment is purified.
- pCH216 Hadfield, 1994 In: Molecular Genetics of Yeast. A Practical Approach. Johnston, J.R. (ed.). Oxford University Press, Oxford, UK, pp. 17-48) containing the APTI gene, conferring resistance to the antibiotic G418.
- the APTI gene is transcribed from a yeast PGKl promoter which makes it usable as a dominant selectable marker in brewer's yeasts at a concentration of 30 mg/ml on YPD plates (rich medium).
- the resulting plasmid construct (see Figure 6) is devoid of yeast 2 ⁇ origin of replication sequences, making self-replication in yeast impossible.
- yeast with this construct requires the integration of the whole plasmid into the yeast genome.
- Integration of the plasmid is obtained through employment of the first part ('loop-in') of the method for replacement of chromosome segments in yeast described by Scherer and Davis, 1979, PNAS USA 76:4951-495.
- the plasmid needs to be linearized in one of the yeast DNA sequences that it harbors (Orr— Weaver, et al, 1981 PNAS USA 78:6354-6358). Linearization is, therefore, performed through restriction digestion at the unique Ngo AIV site (with any of the isoschizomers NgoAYV, Nael, NgoMI or r ⁇ I) in the PRBl gene, and the resulting linear D ⁇ A used to transform S. carlsbergensis brewer's yeast to G418-resistance.
- G418-resistant yeast clones are then checked for integration of the plasmid containing the 17 kDa Foam Protein expression cassette at the proper location in the wildtype PRBl gene. The functionality of the latter gene will not be changed, as none of the gene is missing after proper integration.
- the content of 17 kDa Foam Protein varied widely within this set of samples. About 8 times more 17 kDa Foam Protein was extracted from the cultivar Maresi than from Polygena and Optima under the specified extraction conditions
- 17 kDa Foam Protein may be linked to total protein content within a variety.
- One of these samples had about 50% more total protein than the other and also about 50% more 17 kDa Foam Protein.
- 17 kDa Foam Protein there is no correlation between 17 kDa Foam Protein and total protein. The ratio of
- 17 kDa Foam Protein in the samples varies from approximately 0.5-2 mg 17 kDa protein/g total protein (Table 9).
- the barley extract On Western blotting, the barley extract gave a double band with a molecular mass of approximately 17-18 kDa ( Figure 8, lane C).
- the identity of the two bands from the barley extract was investigated by blotting from SDS-PAGE onto a PNDF membrane, staining shortly with Comassie blue stain and cutting out each of the two bands separately.
- the N-terminal sequence of the first 4-8 amino acids of the proteins corresponding to the two bands was then determined as described in Analytical Procedures. Both bands gave a sequence identical to the N- terminal sequence of 17 kDa Foam Protein (Table 1) and therefore probably represent isoforms of 17 kDa Foam Protein.
- the rye extract ( Figure 8, lane A) gave three major bands at approximately 15, 17 and 20 kDa, whereas the wheat extract (lane B) gave two bands at approximately 17 and 20 kDa. Apart from these bands, faint bands were observed at higher molecular mass from the rye and wheat extracts.
- the antibodies to 17 kDa Foam Protein from barley recognize components in wheat and rye with approximately the same molecular mass.
- the amino acid sequence and/or the tertiary structure of these components are expected to be very similar to the 17 kDa Foam Protein from barley.
- a transformation cassette useful for introducing enhanced amounts of 17 kDa Foam Protein into barley is shown in Figure 9.
- the cassette which includes the hor 3-1 promoter; the 17 kDa Foam Protein coding sequence; and the NOS terminator, is transformed into barley.
- Transformed lines identified by PCR screening for the presence of transgene, are grown to maturity.
- Transformed lines expressing enhanced levels of 17 kDa Foam Protein in the grain are identified by using the ELIZA assay described in Example 10, and the selected lines are bred to homozygosity for the transgene.
- Homozygous GMO barley lines expressing enhanced levels of 17 kDa Foam Protein are then crossed with GMO barley expressing enhanced levels of LTPl.
- GMO barley lines transformed with a chimeric LTPl gene cassette (Chi26 promoter-Ltpl or Hor3-l promoter-Ltpl) which accumulate enhanced levels of LTPl in the mature grain.
- Hybrid GMO barley lines carrying both LTPl and 17kDa Foam Protein transgenes are then used as a preferred barley for the production of beer and other foaming products.
- Example 21 Isolated Rye Nucleic Acid Sequences Encoding 17 kDa Foam Proteins
- the nucleic acid sequences of three rye genes encoding homologues of the barley and wheat 17 kDa Foam Protein have been determined from cDNA and genomic clones, generated by RT-PCR and PCR amplification respectively.
- the cDNA was selectively amplified from a total RNA population isolated from developing rye (Secale cereale) endosperm tissue harvested 25 days after anthesis, as described by Rechinger, et al. supra.
- the total RNA was reverse transcribed with two antisense primers, whose sequence was based on conserved nucleotide sequences located at the 3' end of the coding sequences of the barley and wheat 17 kDa Foam Protein genes:
- the reverse transcription reactions with 1 mg RNA were performed at 55°C using the TitanTM One Tube RT-PCR System supplied by Boehringer Mannheim GmbH.
- the PCR amplification step was 30 thermocyles (94°C for 30 seconds / 60°C for 30 seconds / 68°C for 30 seconds) followed by 7 minutes at 68°C and the amplification products were analysed by agarose gel electrophoresis.
- cDNA fragments of approximately 440 and 380 nucleotides were isolated, cloned into a pCR 2.1-TOPO plasmid vector (Invitrogen) and the nucleotide sequence of the inserts determined with an AmpliCycleTM Sequencing Kit (Perkin Elmer) on an Applied Biosystems 373 DNA sequencer.
- the nucleotide sequence of the 369 and 435 nucleotide inserts revealed two distinct cDNA sequences [SEQ ID NO:27] and [SEQ ID NO:28], which share close homology to the barley and wheat 17 kDa Foam Protein coding sequences.
- Rye genomic sequences encoding homologues of the barley 17 kDa Foam Protein were determined from genomic DNA fragments amplified by PCR. Rye grain were germinated and grown in the dark for 6 days and genomic DNA was prepared from the etiolated leaves using a Plant DNA Isolation Kit from Boehringer Mannheim GmbH. Rye genomic DNA (0.1 mg) was amplified with 25 pmol each of the sense primer [SEQ ID NO:26] and the antisense primer [SEQ ID NO:24], using native P/w DNA polymerase (Stratagene) in a reaction mixture recommended by the manufacturer.
- the PCR amplification was performed using a 'touch-down' thermocycling program (95°C for 0.45 minutes, 68 °C [- 1 °C / cycle (54 °C) ] for 0.45 minutes and 72 °C for 2 minutes for 15 cycles; 95 °C for 0.45 minutes, 54 °C for 0.45 minutes and 72 °C for 2 minutes for 25 cycles; 72 °C for 6 minutes).
- the amplification products were analysed by agarose gel electrophoresis and DNA fragments of approximately 440 nucleotides were isolated, cloned into a pCR- Bluntll TOPO vector (Invitrogen) and sequenced as described for the cDNA fragments.
- the nucleotide sequences of the cloned fragments revealed three distinct gene sequences present in the rye genome, which all showed homology to the barley 17 kDa Foam Protein gene.
- Two of the rye gene sequences [SEQ ID NO:29] and [SEQ ID NO:31] showed identity to the cDNA clones, [SEQ ID NO:27] and [SEQ ID NO:28] respectively, while a third had a distinct sequence [SEQ ID NO:33].
- Alignment of the nucleotide sequences of the rye genes with the barley 17 kDa Foam Protein gene indicates that the amplified rye sequences, including the primers, encode homologues of the 17 kDa Foam Protein starting at the second residue of the mature barley 17 kDa Foam Protein and extending to 7 residues short of the C-terminus.
- the amino acid sequences of the deduced rye 17 kDa Foam Protein homologues are aligned with the barley and wheat 17 kDa Foam Protein sequences in Table 10, where the rye gene shown in SEQ ID NO:29 encodes the rye polypeptide shown in SEQ ID NO:30, the rye gene shown in SEQ ID NO:31 encodes the rye polypeptide shown in SEQ ID NO:32, and the rye gene shown in SEQ ID NO:33 encodes the rye polypeptide shown in SEQ ID NO:34.
- Amino acid identity is represented by ellipses (....)
- amino acid deletions are represented by a dashed line ( )
- the alignment end is represented by an asterisk (*).
- the N- terminal amino acid sequence of the deduced rye 17 kDa Foam Proteins shown in SEQ ID NOS:32 and 34 are almost identical to that of two unidentified rye polypeptides of 15 and 18 kDa, previously detected in a rye grain extract (Rocher et al., 1996, BBA 1295: 13-22).
- the rye 17 kDa Foam Protein shown in SEQ ID NO:34 is 11 amino acid residues smaller than the protein shown in SEQ ID NO:32 due to a 33 nucleotide deletion in its gene.
- the conserved cysteine residues found in the barley and wheat 17 kDa Foam Protein homologues are also conserved in all the rye homologues.
- GGTTCCGATT GAGATAACGA GGATGGTGCT TCAGACCCTT CCGTCGATGT GCAGCGTGAA
- GGTTCCGATT GAGATAACGA GGATGGTGCT TCAGACCCTT CCGTCGATGT GCAGCGTGAA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14670398A | 1998-09-03 | 1998-09-03 | |
| US146703 | 1998-09-03 | ||
| US11575699P | 1999-01-13 | 1999-01-13 | |
| PCT/IB1999/001597 WO2000014237A2 (en) | 1998-09-03 | 1999-09-02 | 17 kDa FOAM PROTEIN |
| US115756P | 2008-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1108031A2 true EP1108031A2 (de) | 2001-06-20 |
Family
ID=26813530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99943182A Withdrawn EP1108031A2 (de) | 1998-09-03 | 1999-09-02 | 17 kda schaumprotein |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1108031A2 (de) |
| AU (1) | AU5645199A (de) |
| CA (1) | CA2341760A1 (de) |
| WO (1) | WO2000014237A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0212885D0 (en) * | 2002-06-05 | 2002-07-17 | Isis Innovation | Therapeutic epitopes and uses thereof |
| US7550579B2 (en) | 2005-04-29 | 2009-06-23 | Pioneer Hi-Bred International, Inc. | Pericarp-preferred regulatory element |
| JP7081905B2 (ja) * | 2016-06-03 | 2022-06-07 | キリンホールディングス株式会社 | ビールテイスト発酵アルコール飲料およびその製造方法 |
| BE1023835B1 (nl) * | 2016-07-04 | 2017-08-07 | Duvel Moortgat Nv | Werkwijze voor het brouwen van bier met een gestandaardiseerde schuimstabiliteit en bier met een gestandaardiseerde schuimstabiliteit |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826765A (en) * | 1986-10-24 | 1989-05-02 | The United States Of America As Represented By The Secretary Of The Agriculture | Yeast strains genetically engineered to produce wheat gluten proteins |
| DK126693D0 (da) * | 1993-11-08 | 1993-11-08 | Carlsberg As | Drikkevare |
| IT1290858B1 (it) * | 1996-12-19 | 1998-12-14 | Mini Ricerca Scient Tecnolog | Isolamento e caratterizzazione di un gene codificante per una glutenina a basso peso molecolare |
-
1999
- 1999-09-02 EP EP99943182A patent/EP1108031A2/de not_active Withdrawn
- 1999-09-02 AU AU56451/99A patent/AU5645199A/en not_active Abandoned
- 1999-09-02 CA CA002341760A patent/CA2341760A1/en not_active Abandoned
- 1999-09-02 WO PCT/IB1999/001597 patent/WO2000014237A2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0014237A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5645199A (en) | 2000-03-27 |
| CA2341760A1 (en) | 2000-03-16 |
| WO2000014237A3 (en) | 2000-08-31 |
| WO2000014237A2 (en) | 2000-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kreis et al. | Primary structure and differential expression of β‐amylase in normal and mutant barleys | |
| US7531723B2 (en) | Modulation of cytokinin activity in plants | |
| US5633440A (en) | P119 promoters and their uses | |
| US7214851B2 (en) | Bzip type transcription factors regulating the expression of rice storage protein | |
| WO1996004781A1 (en) | Plant group 2 promoters and uses thereof | |
| WO1992005258A1 (en) | Gene encoding barley enzyme | |
| US5767379A (en) | Commercial production of avidin in plants | |
| WO1997017455A9 (en) | Commercial production of avidin in plants | |
| JP2001512318A (ja) | 植物における成熟タンパク質の産生 | |
| WO2001083792A2 (en) | Enhanced gene expression in plants using transcription factors | |
| US7390936B1 (en) | Commercial production of chymosin in plants | |
| Klemsdal et al. | Primary structure of a novel barley gene differentially expressed in immature aleurone layers | |
| Willingham et al. | Molecular cloning of the Arabidopsis thaliana sedoheptulose-1, 7-biphosphatase gene and expression studies in wheat and Arabidopsis thaliana | |
| AU5434499A (en) | Polynucleotide sequences | |
| WO2000014237A2 (en) | 17 kDa FOAM PROTEIN | |
| USRE39685E1 (en) | Method for shortening internode of inflorescence by introducing gene for petunia transcription factor petSPL2 | |
| US6031155A (en) | Arabinoxylan degradation | |
| AU778100B2 (en) | Control of sporocyte or meiocyte formation in plants | |
| US6271440B1 (en) | Plant regulatory proteins III | |
| US7074986B1 (en) | Construction of barley with reduced gel protein content | |
| AU9471298A (en) | Banana proteins, dna, and dna regulatory elements associated with fruit development | |
| EP1216306B1 (de) | Kommerzielle herstellung von chymosin in pflanzen | |
| EP0834558A2 (de) | Gen kodierend für Pflanze-Indolacetaldehyd-Oxidase und seine Verwendung | |
| JPWO2001011946A1 (ja) | ゲルタンパク質低減オオムギの作出 | |
| JP2001352981A (ja) | ファイトスルフォカイン前駆体遺伝子のプロモーター |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010326 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20030423 |